24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet [Wellbutrin]
bupropion hydrochloride
RxCUI: 993545
What the CMS Formulary Data Shows for 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet [Wellbutrin]
Per the CMS 2026 Part D formulary file, 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet [Wellbutrin] (RxNorm concept RXCUI 993545, generic name bupropion hydrochloride) appears on 2 distinct formulary files spanning 8 Medicare Part D plan offerings - 0.2% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 3.
Real-world access to 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet [Wellbutrin] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 50% require step therapy. 100% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet [Wellbutrin] today.
Coverage Details
- Formularies covering
- 2
- Plans covering
- 8
- Coverage rate
- 0.2%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 50% of formularies
- Quantity limits
- 100% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet [Wellbutrin]
8 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $0 | NY |
| Hamaspik Medicare Select (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $34.50 | NY |
| Keystone 65 Select Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T5 | No | $47.00 | PA |
| Keystone 65 Preferred Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T5 | No | $59.70 | PA |
| Keystone 65 Select Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T5 | No | $63.50 | PA |
| Keystone 65 Preferred Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T5 | No | $79.70 | PA |
| Personal Choice 65 Rx (PPO) | QCC INSURANCE COMPANY | T5 | No | $102.20 | PA |
| Personal Choice 65 Rx (PPO) | QCC INSURANCE COMPANY | T5 | No | $112.70 | PA |
Frequently Asked Questions
Is 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet [Wellbutrin] covered by Medicare Part D?
Yes, 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet [Wellbutrin] is covered by 8 Medicare Part D plans (0.2% of all Part D formularies).
What tier is 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet [Wellbutrin] on Medicare Part D plans?
24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet [Wellbutrin] averages Tier 3 across Part D plans, ranging from Tier 1 to Tier 5.
Does 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet [Wellbutrin] require prior authorization?
0% of Part D formularies require prior authorization for 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet [Wellbutrin]. Step therapy: 50%. Quantity limits: 100%.
Read our methodology - how this data is sourced, computed, and verified.